Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Continuous Glucose Monitoring Devices Market to Reach US$16 Billion by 2034 as Connected Diabetes Care Adoption Accelerates

globenewswire.com
ABT Abbott is listed as a key competitor in the growing Continuous Glucose Monitoring Devices Market, indicating its involvement in this expanding sector. DXCM Dexcom is identified as a key player in the Continuous Glucose Monitoring Devices Market, which is projected to grow significantly. MDT Medtronic is mentioned as a key competitor in the Continuous Glucose Monitoring Devices Market, highlighting its participation in this growing industry. SNSE Senseonics is listed as a company covered in the assessment of the Continuous Glucose Monitoring Devices Market, indicating its presence in this sector. TNDM Tandem Diabetes Care is identified as a key competitor in the Continuous Glucose Monitoring Devices Market, which is experiencing growth.

Continuous Glucose Monitoring Devices Market to Reach US$16 Billion by 2034 as Connected Diabetes Care Adoption Accelerates Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Continuous Glucose Monitoring Devices Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.

The global Continuous Glucose Monitoring Devices Market is valued at US$8.5 billion in 2026 and is projected to reach US$16 billion by 2034, expanding at a compound annual growth rate of 9.2%. Market growth is being supported by the rising prevalence of diabetes, increasing demand for real-time glucose insights, reduced reliance on fingerstick testing, and stronger clinical adoption of data-driven diabetes management.

Demand is increasingly influenced by factory-calibrated sensors, real-time mobile connectivity, extended sensor wear, improved accuracy, broader reimbursement coverage, and integration with insulin pumps and automated insulin delivery systems.

North America remains the largest regional market, supported by established reimbursement pathways, high diabetes technology adoption, and a strong presence of leading device manufacturers. Europe and Asia-Pacific are expected to record significant growth as healthcare systems modernize diabetes care, expand access to connected monitoring technologies, and strengthen remote patient management capabilities.

Key Continuous Glucose Monitoring Devices Market Insights

Competitive Landscape

Competition in the Continuous Glucose Monitoring Devices Market is intensifying as glucose sensing companies, diabetes technology providers, insulin device manufacturers, pharmacies, and digital health businesses expand their connected care portfolios. Product launches, strategic partnerships, technology collaborations, acquisitions, investment activity, and regional expansion remain central to competitive positioning.

Companies covered in the market assessment include Abbott, Dexcom, Medtronic, Senseonics, Roche, Novo Nordisk, Insulet, Tandem Diabetes Care, Ypsomed, Ascensia Diabetes Care, Sinocare, MicroTech Medical, POCTech, Medtrum, i-SENS, Terumo, Acon Laboratories, Menarini, Biolinq, and GlucoTrack.

Strategic Market Intelligence and Forecasting

The Continuous Glucose Monitoring Devices Market report provides decision-ready analysis of market size, growth forecasts, technology trends, competitive positioning, supply-demand conditions, pricing, trade flows, and regional opportunities. Analytical coverage includes Porter's Five Forces, value chain mapping, scenario-based forecasting, company benchmarking, and assessment of market entry and expansion strategies.

The study evaluates how regulatory developments, reimbursement policies, macroeconomic conditions, sourcing risks, trade dependencies, and changing customer expectations may affect product availability, pricing, profitability, and investment priorities. It also identifies high-growth opportunities across product types, technologies, applications, end users, digital health integration, and insulin delivery ecosystems.

Geographic Coverage

Research Methodology

The market study combines primary interviews with participants across the Continuous Glucose Monitoring Devices value chain and secondary research from government publications, industry associations, trade databases, regulatory sources, and verified company disclosures. Data triangulation, statistical analysis, and scenario planning are used to support market sizing, segmentation, competitive analysis, and forecasts through 2034.

Key Questions Addressed

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/6sk132

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.